Class 1 Integrons in Clinical Multi Drug Resistance E. coli, Sana’a Hospitals, Yemen | Zendy

Mukhtar Abdullah Al-Hammadi | Zendy; Hassan Abdulwahab Al-Shamahy | Zendy; Abdulaziz Qaid Ali | Zendy; Mahfoudh A. M. Abdulghani | Zendy; Hassan Pyar | Zendy; Ibrahim AL-Suboal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Class 1 Integrons in Clinical Multi Drug Resistance E. coli, Sana’a Hospitals, Yemen

Author(s) -

Mukhtar Abdullah Al-Hammadi,

Hassan Abdulwahab Al-Shamahy,

Abdulaziz Qaid Ali,

Mahfoudh A. M. Abdulghani,

Hassan Pyar,

Ibrahim AL-Suboal

Publication year - 2020

Publication title -

pakistan journal of biological sciences

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 0.268

H-Index - 43

eISSN - 1812-5735

pISSN - 1028-8880

DOI - 10.3923/pjbs.2020.231.239

Subject(s) - integron , cefepime , aztreonam , clavulanic acid , ceftazidime , imipenem , amikacin , microbiology and biotechnology , medicine , amoxicillin , ciprofloxacin , nitrofurantoin , ceftriaxone , drug resistance , trimethoprim , sulfamethoxazole , antibiotic resistance , antibiotics , biology , bacteria , pseudomonas aeruginosa , genetics

The occurrence of multi-drug resistance (MDR) Escherichia coli is one responsible for raised mortality and morbidity and was reported as major health problem. Class 1 integrons has crucial role in distributing antibiotic resistance genes among bacteria. Present work was aimed to determine the prevalence of class 1 integrons and its association with antibiotic resistance in MDR E. coli isolated from patient's body fluid and tissues from 6 health centers in Sana'a, Yemen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research